China Investigating Drug Pricing At Domestic, Multinational Firms

The Chinese government is conducting a review of drug pricing and manufacturing costs at certain domestic and international companies, with an eye on making healthcare more accessible to its people. The review will look at drugmakers’ data from 2010 through 2012, including sales agreements and shipping records.
International Pharmaceutical Regulatory Monitor